<DOC>
<DOCNO>
EP-0010313
</DOCNO>
<TEXT>
<DATE>
19800430
</DATE>
<IPC-CLASSIFICATIONS>
A61P-31/00 C07D-501/30 C07D-501/34 C07D-501/60 <main>C07D-501/18</main> A61K-31/545 C07D-501/18 A61K-31/546 C07D-501/00 C07D-501/26 C07D-501/28 C07D-501/38 C07D-501/14 A61P-31/04 C07D-501/20 
</IPC-CLASSIFICATIONS>
<TITLE>
3,7-disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical co jp <sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>fujisawa pharmaceutical co., ltd.<sep>
</APPLICANT>
<INVENTOR>
kobayashi masakazu<sep>ono hiroki<sep>ueda ikuo<sep>yamada hisashi<sep>kobayashi, masakazu<sep>ono, hiroki<sep>ueda, ikuo<sep>yamada, hisashi<sep>kobayashi, masakazuno. 1.5.2, hachitsukaikedajp<sep>ono, hirokino. 18-4, babamibashirinagaokakyojp<sep>ueda, ikuono. 4-13-36, kumanochotoyonakajp<sep>yamada, hisashino. 2-2-10, midorigackaikedajp<sep>kobayashi, masakazu <sep>ono, hiroki<sep>ueda, ikuo  <sep>yamada, hisashi <sep>kobayashi, masakazuno. 1.5.2, hachitsukaikedajp<sep>ono, hirokino. 18-4, babamibashirinagaokakyojp<sep>ueda, ikuono. 4-13-36, kumanochotoyonakajp<sep>yamada, hisashino. 2-2-10, midorigackaikedajp<sep>
</INVENTOR>
<ABSTRACT>
new 3,7-disubstituted-2 or 3-cephem-4-carboxylic acid  compounds of the formula:    wherein   r¹ is amino or a substituted amino group;   r² is carboxy or a protected carboxy group;   the group of the formula:    is di(lower)alkylamino (lower)alkylamino, a n-containing  heterocyclic (lower)alkylamino group which may have suitable  substituent(s), a heterocyclic group containing 2 to 4  nitrogen atoms which may have suitable substituent(s) or  hydroxypiperidino; and x is -s- or 0;   -s- e. g.  7-­ [2-methoxyimino-2- (2-aminothiazol-4-yl) acetamido]  -3-(4-methyl-1-piperazinyl) carbonyloxymethyl-3-cephem  -4-carboxylic acid (syn isomer);  pharmaceutically acceptable salts thereof; and processes for  their preparation.  the invention also relates to pharmaceutical  compositions comprising, as an effective ingredient, the  above compounds in association with a pharmaceutically  acceptable, substantially nontoxic carrier or excipient; and to  a process for their preparation.  
</ABSTRACT>
</TEXT>
</DOC>
